Skip to main content
Top
Published in: Inflammation Research 1/2017

01-01-2017 | Commentary

M2 macrophages do not fly into a “RAGE”

Authors: Armando Rojas, Carolina Añazco, Paulina Araya

Published in: Inflammation Research | Issue 1/2017

Login to get access

Abstract

Tumor-associated macrophages (TAMs) are key elements in orchestrating host responses inside tumor stroma. This population may undergo a polarized activation process, thus rendering a heterogeneous spectrum of phenotypes, where the classically activated type 1 macrophages (M1) and the alternative activated type 2 macrophages (M2) represent two extreme phenotypes. In this commentary, based on very recent research findings, we intend to highlight how complex could be the crosstalk among all components of tumor stroma, where the coexistence of non-natural partners may even skew the canonical responses that we can expect.
Literature
1.
2.
go back to reference Rojas A, Morales MA. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 2004;76:715–30.CrossRefPubMed Rojas A, Morales MA. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci. 2004;76:715–30.CrossRefPubMed
3.
go back to reference Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 1996;45:S77–80.CrossRefPubMed Schmidt AM, Hori O, Cao R, Yan SD, Brett J, Wautier JL, Ogawa S, Kuwabara K, Matsumoto M, Stern D. RAGE: a novel cellular receptor for advanced glycation end products. Diabetes. 1996;45:S77–80.CrossRefPubMed
4.
go back to reference Rojas A, Delgado-López F, González I, Pérez-Castro R, Romero J, Rojas I. The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor. Cell Signal. 2013;25:609–14.CrossRefPubMed Rojas A, Delgado-López F, González I, Pérez-Castro R, Romero J, Rojas I. The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor. Cell Signal. 2013;25:609–14.CrossRefPubMed
5.
go back to reference Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem. 2010;17:2232–52.CrossRefPubMed Alexiou P, Chatzopoulou M, Pegklidou K, Demopoulos VJ. RAGE: a multi-ligand receptor unveiling novel insights in health and disease. Curr Med Chem. 2010;17:2232–52.CrossRefPubMed
6.
go back to reference González I, Romero J, Rodríguez BL, Pérez-Castro R, Rojas A. The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology. 2013;218:790–7.CrossRefPubMed González I, Romero J, Rodríguez BL, Pérez-Castro R, Rojas A. The immunobiology of the receptor of advanced glycation end-products: trends and challenges. Immunobiology. 2013;218:790–7.CrossRefPubMed
7.
go back to reference van Zoelen MA, Achouiti A, van der Poll T. RAGE during infectious diseases. Front Biosci (Schol Ed). 2011;1(3):1119–32.CrossRef van Zoelen MA, Achouiti A, van der Poll T. RAGE during infectious diseases. Front Biosci (Schol Ed). 2011;1(3):1119–32.CrossRef
8.
go back to reference Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med. 2007;7:711–24.CrossRefPubMed Donato R. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins. Curr Mol Med. 2007;7:711–24.CrossRefPubMed
10.
go back to reference Rojas A, Figueroa H, Morales E. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis. 2010;31:334–41.CrossRefPubMed Rojas A, Figueroa H, Morales E. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis. 2010;31:334–41.CrossRefPubMed
11.
go back to reference Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.CrossRefPubMed Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21:309–22.CrossRefPubMed
13.
go back to reference Thakur R, Mishra DP. Matrix reloaded: CCN, Tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities. Pharmacol Ther. 2016. Thakur R, Mishra DP. Matrix reloaded: CCN, Tenascin and SIBLING group of matricellular proteins in orchestrating cancer hallmark capabilities. Pharmacol Ther. 2016.
14.
go back to reference Multhaupt HA, Leitinger B, Gullberg D, Couchman JR. Extracellular matrix component signaling in cancer. Adv Drug Deliv Rev. 2016;97:28–40.CrossRefPubMed Multhaupt HA, Leitinger B, Gullberg D, Couchman JR. Extracellular matrix component signaling in cancer. Adv Drug Deliv Rev. 2016;97:28–40.CrossRefPubMed
16.
go back to reference Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol. 2013;228:1404–12.CrossRefPubMed Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol. 2013;228:1404–12.CrossRefPubMed
17.
go back to reference Augsten M. Cancer-associa ted fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;27(4):62. Augsten M. Cancer-associa ted fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;27(4):62.
18.
go back to reference Motwani MP, Gilroy DW. Macrophage development and polarization in chronic inflammation. Semin Immunol. 2015;27:257–66.CrossRefPubMed Motwani MP, Gilroy DW. Macrophage development and polarization in chronic inflammation. Semin Immunol. 2015;27:257–66.CrossRefPubMed
19.
go back to reference Komohara Y, Fujiwara Y, Ohnishi K, Takeya M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev. 2016;99(Pt B):180–5. Komohara Y, Fujiwara Y, Ohnishi K, Takeya M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. Adv Drug Deliv Rev. 2016;99(Pt B):180–5.
20.
go back to reference Jinushi M, Komohara Y. Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta. 2015;1855:123–30.PubMed Jinushi M, Komohara Y. Tumor-associated macrophages as an emerging target against tumors: creating a new path from bench to bedside. Biochim Biophys Acta. 2015;1855:123–30.PubMed
22.
go back to reference Sica A, Erreni M, Allavena P, Porta C. Macrophage polarization in pathology. Cell Mol Life Sci. 2015;72:4111–26.CrossRefPubMed Sica A, Erreni M, Allavena P, Porta C. Macrophage polarization in pathology. Cell Mol Life Sci. 2015;72:4111–26.CrossRefPubMed
23.
go back to reference Novoselov VV, Sazonova MA, Ivanova EA. Orekhov AN Study of the activated macrophage transcriptome. Exp Mol Pathol. 2015;99:575–80.CrossRefPubMed Novoselov VV, Sazonova MA, Ivanova EA. Orekhov AN Study of the activated macrophage transcriptome. Exp Mol Pathol. 2015;99:575–80.CrossRefPubMed
24.
go back to reference Becker M, De Bastiani MA, Parisi MM, Guma FT, Markoski MM, Castro MA, Kaplan MH, Barbé-Tuana FM, Klamt F. Integrated transcriptomics establish macrophage polarization signatures and have potential applications for clinical health and disease. Sci Rep. 2015;5:13351. doi:10.1038/srep13351.CrossRefPubMedPubMedCentral Becker M, De Bastiani MA, Parisi MM, Guma FT, Markoski MM, Castro MA, Kaplan MH, Barbé-Tuana FM, Klamt F. Integrated transcriptomics establish macrophage polarization signatures and have potential applications for clinical health and disease. Sci Rep. 2015;5:13351. doi:10.​1038/​srep13351.CrossRefPubMedPubMedCentral
25.
go back to reference Rojas A, Delgado-López F, Perez-Castro R, Gonzalez I, Romero J, Rojas I, Araya P, Añazco C, Morales E, Llanos E. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biol. 2016;37:3321–9.CrossRefPubMed Rojas A, Delgado-López F, Perez-Castro R, Gonzalez I, Romero J, Rojas I, Araya P, Añazco C, Morales E, Llanos E. HMGB1 enhances the protumoral activities of M2 macrophages by a RAGE-dependent mechanism. Tumour Biol. 2016;37:3321–9.CrossRefPubMed
26.
go back to reference Rojas A, Araya P, Romero J, Delgado-López F, Pérez-Castro R, González I, Añazco A, Morales E, Llanos J, Vidal-Vanaclocha F. HMGB1-mediated RAGE activation mechanism in M2 macrophages [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research. 2016 Apr 16–20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76 (14 Suppl):Abstract nr 725. Rojas A, Araya P, Romero J, Delgado-López F, Pérez-Castro R, González I, Añazco A, Morales E, Llanos J, Vidal-Vanaclocha F. HMGB1-mediated RAGE activation mechanism in M2 macrophages [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research. 2016 Apr 16–20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76 (14 Suppl):Abstract nr 725.
27.
go back to reference Huber R, Meier B, Otsuka A, Fenini G, Satoh T, Gehrke S, Widmer D, Levesque MP, Mangana J, Kerl K, Gebhardt C, Fujii H, Nakashima C, Nonomura Y, Kabashima K, Dummer R, Contassot E, French LE. Tumour hypoxia promotes melanoma growth and metastasis via high mobility GROUP box-1 and M2-like macrophages. Sci Rep. 2016;18(6):29914. doi:10.1038/srep29914.CrossRef Huber R, Meier B, Otsuka A, Fenini G, Satoh T, Gehrke S, Widmer D, Levesque MP, Mangana J, Kerl K, Gebhardt C, Fujii H, Nakashima C, Nonomura Y, Kabashima K, Dummer R, Contassot E, French LE. Tumour hypoxia promotes melanoma growth and metastasis via high mobility GROUP box-1 and M2-like macrophages. Sci Rep. 2016;18(6):29914. doi:10.​1038/​srep29914.CrossRef
28.
go back to reference Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013;332:3–10.CrossRefPubMed Tang X. Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Lett. 2013;332:3–10.CrossRefPubMed
29.
go back to reference Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat. 2013;12:259–67.PubMed Lan C, Huang X, Lin S, Huang H, Cai Q, Wan T, Lu J, Liu J. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer. Technol Cancer Res Treat. 2013;12:259–67.PubMed
Metadata
Title
M2 macrophages do not fly into a “RAGE”
Authors
Armando Rojas
Carolina Añazco
Paulina Araya
Publication date
01-01-2017
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 1/2017
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-016-0994-2

Other articles of this Issue 1/2017

Inflammation Research 1/2017 Go to the issue